Apotheek Bytebier-Van Antwerpen
ActiveSummary
Apotheek Bytebier-Van Antwerpen has been active since 1952 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.5m and a net result of €258,780. Equity has been growing by about 26% per year since 2018. Its solvency ranks better than 90% of 12,775 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
Official details
Source: KBO- Status
- Active since 30-03-1952 Normal situation
- Activity
- Retail sale of pharmaceutical products NACE 47730
- Joint committee
- 313 Paritair Comité voor de apotheken en tarificatiediensten · annual accounts 2025
- Establishment units
- 2.071.684.428 2630 Aartselaar, since 22-05-1995
- 2.226.410.217 2650 Edegem, since 27-01-2014
- Financial year end
- 31 December
- Peppol
- Reachable
Board and ownership
- VAN ANTWERPEN MarijkeDirector · since 01-04-1982
- RIMKA PHARMA99.7%· score 832025 annual accounts of RIMKA PHARMA
Financial position
- Bankruptcy probabilitywithin 12 months
- < 0.1%
- Gross margin
- €639,926
- ▲ 5.2%
- Turnover
- ≈ €2.3m
- estimated
- Profit
- €258,780
- ▲ 11.9%
- Equity
- €1.5m
- ▲ 21.1%
- Total assets
- €1.8m
- ▲ 24.9%
- Employees on 31-12-2025
- 7
- ▲ 16.7%
Score breakdownraises riskSector: Retail trade (NACE 47)lowers riskLiquidity: current ratio 5.14, cash €473,441Founded in 1952Equity €1.5m (81.1% of total assets)Show the evidence
Checked score
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 92% of them on solvency, 82% on liquidity, 81% on profitability and 73% on growth.
The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 16 days after the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
Key points
Recent changes
- · Gazette deed Change of role: BYTEBIER Ronan, from statutory director to gewone bestuurderAppointment: VAN ANTWERPEN Marijke (gewone bestuurder)
Comparable companies
These companies have the same main activity as Apotheek Bytebier-Van Antwerpen: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1.4m and €2.4m, founded between 1968 and 1981.
| Company | Total assets | Gross margin |
|---|---|---|
| Apotheek Bytebier-Van Antwerpen Aartselaar | €1.8m | €0.6m |
| Pharmacie Garin Jodoigne | €1.4m | €0.7m |
| APOTHEEK BEAUJEAN CENTRUM Halle | €1.5m | €0.6m |
| APOTHEEK HEYLEN Nijlen | €2.4m | €0.6m |
| APOTHEEK TUYTELAARS Malle | €2.1m | €0.5m |
| APOTHEEK ANDRÉ DUMONT Maasmechelen | €1.7m | €0.5m |
| Apotheek Seurinck Ingelmunster | €2.0m | €0.6m |
Key facts about Apotheek Bytebier-Van Antwerpen
- What is the company number of Apotheek Bytebier-Van Antwerpen?
- The company number of Apotheek Bytebier-Van Antwerpen is 0403.668.963. The VAT number is the same number with BE in front: BE 0403.668.963.
- Where is Apotheek Bytebier-Van Antwerpen based?
- The registered office is at Guido Gezellestraat 10, 2630 Aartselaar.Company details
- What does Apotheek Bytebier-Van Antwerpen do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of Apotheek Bytebier-Van Antwerpen?
- The legal form of Apotheek Bytebier-Van Antwerpen is Private limited company (BV).
- When was Apotheek Bytebier-Van Antwerpen founded?
- Apotheek Bytebier-Van Antwerpen was founded on 30-03-1952.
- Is Apotheek Bytebier-Van Antwerpen still active?
- Yes, Apotheek Bytebier-Van Antwerpen is an active enterprise in the KBO register.
- How many employees does Apotheek Bytebier-Van Antwerpen have?
- Apotheek Bytebier-Van Antwerpen had an average of 4.1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does Apotheek Bytebier-Van Antwerpen fall under?
- In its 2025 annual accounts, Apotheek Bytebier-Van Antwerpen states joint committee 313 (Paritair Comité voor de apotheken en tarificatiediensten).
- What is the turnover of Apotheek Bytebier-Van Antwerpen?
- The turnover in financial year 2025 is ≈ €2.3m. This figure is estimated from the gross margin of €639,926 and 47 comparable companies (NACE 477). It probably lies between €1.8m and €3.8m.
- Is Apotheek Bytebier-Van Antwerpen profitable?
- In financial year 2025, Apotheek Bytebier-Van Antwerpen made a profit of €258,780.
- Where can I find the annual accounts of Apotheek Bytebier-Van Antwerpen?
- Apotheek Bytebier-Van Antwerpen filed 49 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Apotheek Bytebier-Van Antwerpen due?
- Apotheek Bytebier-Van Antwerpen must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.